Cerecor discovers, develops and commercializes neuroscience drugs.
Cerecor has raised $10.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in August 2021.
Cerecor's investors include New Enterprise Associates, Apple Tree Partners, MPM Capital, National Institutes of Health, Horizon Technology Finance.
Cerecor is headquartered in Baltimore, United States.
Cerecor discovers, develops and commercializes neuroscience drugs.
Cerecor is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cerecor — Funding & Investors." VCBacked, August 2, 2021, https://www.vcbacked.co/company/cerecor. Accessed July 20, 2026.
VCBacked. (2021). Cerecor — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/cerecor
{{cite web |title=Cerecor — Funding & Investors |url=https://www.vcbacked.co/company/cerecor |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated